메뉴 건너뛰기




Volumn 31, Issue 9, 2012, Pages

Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta

Author keywords

7 valent pneumococcal vaccine; Alberta; Canada; epidemiology; invasive pneumococcal disease; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; VITEK 2;

EID: 84865471144     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182624a40     Document Type: Article
Times cited : (28)

References (39)
  • 1
    • 79955509218 scopus 로고    scopus 로고
    • Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: A cross-sectional study
    • Flasche S, Van Hoek AJ, Sheasby E, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med. 2011;8:e1001017.
    • (2011) PLoS Med , vol.8
    • Flasche, S.1    Van Hoek, A.J.2    Sheasby, E.3
  • 2
    • 1442299471 scopus 로고    scopus 로고
    • Streptococcus pneumoniae colonisation: The key to pneumococcal disease
    • Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4: 144-154.
    • (2004) Lancet Infect Dis , vol.4 , pp. 144-154
    • Bogaert, D.1    De Groot, R.2    Hermans, P.W.3
  • 3
    • 46249105801 scopus 로고    scopus 로고
    • Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada
    • Kellner JD, Scheifele D, Vanderkooi OG, et al. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J. 2008;27:526-532.
    • (2008) Pediatr Infect Dis J , vol.27 , pp. 526-532
    • Kellner, J.D.1    Scheifele, D.2    Vanderkooi, O.G.3
  • 4
    • 0019256014 scopus 로고
    • Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life
    • Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 1980;142:923-933.
    • (1980) J Infect Dis , vol.142 , pp. 923-933
    • Gray, B.M.1    Converse III, G.M.2    Dillon Jr., H.C.3
  • 5
    • 85027945050 scopus 로고    scopus 로고
    • Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine
    • Grall N, Hurmic O, Al Nakib M, et al. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis. 2011;30:1511-1519.
    • (2011) Eur J Clin Microbiol Infect Dis , vol.30 , pp. 1511-1519
    • Grall, N.1    Hurmic, O.2    Al Nakib, M.3
  • 6
    • 77951092006 scopus 로고    scopus 로고
    • Streptococcus pneumoniae: Epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines
    • Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16:217-225.
    • (2010) Curr Opin Pulm Med , vol.16 , pp. 217-225
    • Lynch III, J.P.1    Zhanel, G.G.2
  • 7
    • 70350498834 scopus 로고    scopus 로고
    • Pathogenesis, treatment, and prevention of pneumococcal pneumonia
    • van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374:1543-1556.
    • (2009) Lancet , vol.374 , pp. 1543-1556
    • Van Der Poll, T.1    Opal, S.M.2
  • 8
    • 76949094005 scopus 로고    scopus 로고
    • The effect of routine vaccination on invasive pneumococcal infections in Canadian children Immunization Monitoring Program Active 2000-2007
    • Bettinger JA, Scheifele DW, Kellner JD, et al. The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine. 2010;28: 2130-2136.
    • (2010) Vaccine , vol.28 , pp. 2130-2136
    • Bettinger, J.A.1    Scheifele, D.W.2    Kellner, J.D.3
  • 9
    • 67651089517 scopus 로고    scopus 로고
    • Changing epidemiology of invasive pneumococcal disease in Canada 1998-2007: Update from the Calgary-area Streptococcus pneumoniae research (CASPER) study
    • Kellner JD, Vanderkooi OG, MacDonald J, et al. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis. 2009;49:205-212.
    • (2009) Clin Infect Dis , vol.49 , pp. 205-212
    • Kellner, J.D.1    Vanderkooi, O.G.2    MacDonald, J.3
  • 10
    • 0242684416 scopus 로고    scopus 로고
    • Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
    • Active Bacterial Core Surveillance of the Emerging Infections Program Network
    • Whitney CG, Farley MM, Hadler J, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
    • (2003) N Engl J Med , vol.348 , pp. 1737-1746
    • Whitney, C.G.1    Farley, M.M.2    Hadler, J.3
  • 11
    • 13944259416 scopus 로고    scopus 로고
    • Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine
    • Massachusetts Department of Public Health Epidemiologists
    • Hsu K, Pelton S, Karumuri S, et al.; Massachusetts Department of Public Health Epidemiologists. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J. 2005;24:17-23.
    • (2005) Pediatr Infect Dis J , vol.24 , pp. 17-23
    • Hsu, K.1    Pelton, S.2    Karumuri, S.3
  • 12
    • 10744228195 scopus 로고    scopus 로고
    • Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine
    • Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113(3 Pt 1):443-449.
    • (2004) Pediatrics , vol.113 , Issue.3 PART 1 , pp. 443-449
    • Kaplan, S.L.1    Mason Jr., E.O.2    Wald, E.R.3
  • 13
    • 27244440305 scopus 로고    scopus 로고
    • Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
    • Active Bacterial Core Surveillance Team
    • Lexau CA, Lynfield R, Danila R, et al.; Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043-2051.
    • (2005) JAMA , vol.294 , pp. 2043-2051
    • Lexau, C.A.1    Lynfield, R.2    Danila, R.3
  • 14
    • 77954355720 scopus 로고    scopus 로고
    • Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use
    • Pilishvili T, Zell ER, Farley MM, et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics. 2010;126:e9-17.
    • (2010) Pediatrics , vol.126
    • Pilishvili, T.1    Zell, E.R.2    Farley, M.M.3
  • 15
    • 68449097351 scopus 로고    scopus 로고
    • New insights on pneumococcal disease: What we have learned over the past decade
    • Dagan R. New insights on pneumococcal disease: what we have learned over the past decade. Vaccine. 2009;27(suppl 3):C3-C5.
    • (2009) Vaccine , vol.27 , Issue.SUPPL. 3
    • Dagan, R.1
  • 16
    • 78649336856 scopus 로고    scopus 로고
    • Why it is still important that countries know the burden of pneumococcal disease
    • Prato R, Tafuri S, Fortunato F, et al. Why it is still important that countries know the burden of pneumococcal disease. Hum Vaccin. 2010;6:918-921.
    • (2010) Hum Vaccin , vol.6 , pp. 918-921
    • Prato, R.1    Tafuri, S.2    Fortunato, F.3
  • 17
    • 27744582170 scopus 로고    scopus 로고
    • Progress in the prevention of pneumococcal infection
    • Kellner JD, Church DL, MacDonald J, et al. Progress in the prevention of pneumococcal infection. CMAJ. 2005;173:1149-1151.
    • (2005) CMAJ , vol.173 , pp. 1149-1151
    • Kellner, J.D.1    Church, D.L.2    MacDonald, J.3
  • 18
    • 33745627640 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute 9th ed. Approved standard M02-09. Wayne PA: Clinical and Laboratory Standards Institutes
    • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. 9th ed. Approved standard M02-09. Wayne, PA: Clinical and Laboratory Standards Institutes; 2006.
    • (2006) Performance Standards for Antimicrobial Disk Susceptibility Tests
  • 19
    • 33646693907 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute 7th ed. Approved standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 7th ed. Approved standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
    • (2006) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
  • 20
    • 71949118979 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • Clinical and Laboratory Standards Institute Wayne, PA: Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 16th Informational Supplement, M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
    • (2006) 16th Informational Supplement M100-S16
  • 21
    • 84455161879 scopus 로고    scopus 로고
    • Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae Serotypes 5 and 8 in Calgary Canada
    • Vanderkooi O, Church D, MacDonald J, et al. Community-Based Outbreaks in Vulnerable Populations of Invasive Infections caused by Streptococcus pneumoniae Serotypes 5 and 8 in Calgary, Canada. PLoS ONE. 2011;6:e28547.
    • (2011) PLoS ONE , vol.6
    • Vanderkooi, O.1    Church, D.2    MacDonald, J.3
  • 22
    • 71949103062 scopus 로고    scopus 로고
    • Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
    • Active Bacterial Core Surveillance/Emerging Infections Program Network
    • Pilishvili T, Lexau C, Farley MM, et al.; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32-41.
    • (2010) J Infect Dis , vol.201 , pp. 32-41
    • Pilishvili, T.1    Lexau, C.2    Farley, M.M.3
  • 23
    • 78751605959 scopus 로고    scopus 로고
    • A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children
    • Grijalva CG, Pelton SI. A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Curr Opin Pediatr. 2011;23:98-104.
    • (2011) Curr Opin Pediatr , vol.23 , pp. 98-104
    • Grijalva, C.G.1    Pelton, S.I.2
  • 24
    • 79955041157 scopus 로고    scopus 로고
    • Shifting genetic structure of invasive serotype 19A pneumococci in the United States
    • Beall BW, Gertz RE, Hulkower RL, et al. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis. 2011;203:1360-1368.
    • (2011) J Infect Dis , vol.203 , pp. 1360-1368
    • Beall, B.W.1    Gertz, R.E.2    Hulkower, R.L.3
  • 25
    • 27944510953 scopus 로고    scopus 로고
    • Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States
    • Active Bacterial Core Surveillance Team
    • Pai R, Moore MR, Pilishvili T, et al.; Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis. 2005; 192:1988-1995.
    • (2005) J Infect Dis , vol.192 , pp. 1988-1995
    • Pai, R.1    Moore, M.R.2    Pilishvili, T.3
  • 26
    • 75749099291 scopus 로고    scopus 로고
    • Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades
    • Harboe ZB, Benfield TL, Valentiner-Branth P, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis. 2010;50:329-337.
    • (2010) Clin Infect Dis , vol.50 , pp. 329-337
    • Harboe, Z.B.1    Benfield, T.L.2    Valentiner-Branth, P.3
  • 27
    • 0036377943 scopus 로고    scopus 로고
    • Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
    • Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21:810-815.
    • (2002) Pediatr Infect Dis J , vol.21 , pp. 810-815
    • Black, S.B.1    Shinefield, H.R.2    Ling, S.3
  • 28
    • 34047096257 scopus 로고    scopus 로고
    • Decline in pneumonia admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA time series analysis
    • Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA time series analysis. Lancet. 2007;369:1179-1186.
    • (2007) Lancet , vol.369 , pp. 1179-1186
    • Grijalva, C.G.1    Nuorti, J.P.2    Arbogast, P.G.3
  • 29
    • 79955122797 scopus 로고    scopus 로고
    • Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States
    • Simonsen L, Taylor RJ, Young-Xu Y, et al. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011;2:e00309-e00310.
    • (2011) MBio , vol.2
    • Simonsen, L.1    Taylor, R.J.2    Young-Xu, Y.3
  • 30
    • 80053126248 scopus 로고    scopus 로고
    • Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae
    • Lin SH, Lai CC, Tan CK, et al. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect. 2011;139:1307-1316.
    • (2011) Epidemiol Infect , vol.139 , pp. 1307-1316
    • Lin, S.H.1    Lai, C.C.2    Tan, C.K.3
  • 31
    • 58149156472 scopus 로고    scopus 로고
    • Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine
    • Hendrickson DJ, Blumberg DA, Joad JP, et al. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030-1032.
    • (2008) Pediatr Infect Dis J , vol.27 , pp. 1030-1032
    • Hendrickson, D.J.1    Blumberg, D.A.2    Joad, J.P.3
  • 32
    • 33644920167 scopus 로고    scopus 로고
    • Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema
    • Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250-254.
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 250-254
    • Byington, C.L.1    Korgenski, K.2    Daly, J.3
  • 33
    • 79551580116 scopus 로고    scopus 로고
    • PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine
    • Bacterial Meningitis Study Group
    • Levy C, Varon E, Bingen E, et al.; Bacterial Meningitis Study Group. PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011;30:168-170.
    • (2011) Pediatr Infect Dis J , vol.30 , pp. 168-170
    • Levy, C.1    Varon, E.2    Bingen, E.3
  • 34
    • 78649759328 scopus 로고    scopus 로고
    • Rebound in the incidence of pneumococcal meningitis in northern France: Effect of serotype replacement
    • Hospital Network for Evaluating the Management of Common Childhood Diseases
    • Alexandre C, Dubos F, Courouble C, et al.; Hospital Network for Evaluating the Management of Common Childhood Diseases. Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement. Acta Paediatr. 2010;99:1686-1690.
    • (2010) Acta Paediatr , vol.99 , pp. 1686-1690
    • Alexandre, C.1    Dubos, F.2    Courouble, C.3
  • 35
    • 35748967840 scopus 로고    scopus 로고
    • Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France
    • Hospital Network for Evaluating the Management of Common Childhood Diseases
    • Dubos F, Marechal I, Husson MO, et al.; Hospital Network for Evaluating the Management of Common Childhood Diseases. Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France. Arch Dis Child. 2007;92:1009-1012.
    • (2007) Arch Dis Child , vol.92 , pp. 1009-1012
    • Dubos, F.1    Marechal, I.2    Husson, M.O.3
  • 36
    • 58349094326 scopus 로고    scopus 로고
    • Effect of pneumococcal conjugate vaccine on pneumococcal meningitis
    • Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360:244-256.
    • (2009) N Engl J Med , vol.360 , pp. 244-256
    • Hsu, H.E.1    Shutt, K.A.2    Moore, M.R.3
  • 37
    • 41149135524 scopus 로고    scopus 로고
    • Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation
    • Bacterial Meningitis Study Group
    • Bingen E, Levy C, Varon E, et al.; Bacterial Meningitis Study Group. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis. 2008;27:191-199.
    • (2008) Eur J Clin Microbiol Infect Dis , vol.27 , pp. 191-199
    • Bingen, E.1    Levy, C.2    Varon, E.3
  • 38
    • 78649734531 scopus 로고    scopus 로고
    • Pneumococcal meningitis still with us in the era of conjugate vaccines
    • Peltola V. Pneumococcal meningitis still with us in the era of conjugate vaccines. Acta Paediatr. 2010;99:1600-1601.
    • (2010) Acta Paediatr , vol.99 , pp. 1600-1601
    • Peltola, V.1
  • 39
    • 82455162581 scopus 로고    scopus 로고
    • Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
    • Skinner JM, Indrawati L, Cannon J, et al. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine. 2011;29:8870-8876.
    • (2011) Vaccine , vol.29 , pp. 8870-8876
    • Skinner, J.M.1    Indrawati, L.2    Cannon, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.